Results 11 to 20 of about 3,376,929 (374)
Antifungal resistance in dermatology
Cutaneous fungal infections affect more than one-fourth of world's population. The pathogenesis and severity of fungal infection depend on various immunological and nonimmunological factors.
Varadraj Pai +2 more
doaj +3 more sources
Candida Species Biofilms’ Antifungal Resistance [PDF]
Candida infections (candidiasis) are the most prevalent opportunistic fungal infection on humans and, as such, a major public health problem. In recent decades, candidiasis has been associated to Candida species other than Candida albicans.
Sónia Silva +4 more
doaj +4 more sources
Antifungals and Drug Resistance
Antifungal drugs prevent topical or invasive fungal infections (mycoses) either by stopping growth of fungi (termed fungistatic) or by killing the fungal cells (termed fungicidal).
Chowdhury Mobaswar Hossain +6 more
doaj +2 more sources
Antifungal Resistance in Cryptococcal Infections
Antifungal therapy, especially with the azoles, could promote the incidence of less susceptible isolates of Cryptococcus neoformans and C. gattii species complexes (SC), mostly in developing countries.
Marcia S. C. Melhem +10 more
semanticscholar +4 more sources
Fungal Drug Response and Antimicrobial Resistance
Antifungal resistance is a growing concern as it poses a significant threat to public health. Fungal infections are a significant cause of morbidity and mortality, especially in immunocompromised individuals.
Paloma Osset-Trénor +2 more
doaj +1 more source
Antifungal resistance in dermatophytosis: A global health concern
Dermatophytosis is a common dermatological problem in animals as well as humans which is associated with interference in immune function. Unlike the antibacterial resistance which is frequently reported, antifungal resistance is less commonly reported ...
Jubeda Begum, P Das
doaj +1 more source
Tackling the emerging threat of antifungal resistance to human health
Invasive fungal infections pose an important threat to public health and are an under-recognized component of antimicrobial resistance, an emerging crisis worldwide.
M. Fisher +19 more
semanticscholar +1 more source
Antifungal Use and Resistance in a Lower–Middle-Income Country: The Case of Lebanon
Antimicrobial resistance is a serious threat, particularly in low- and middle-income countries (LMICs). Antifungal resistance is often underestimated in both healthcare and non-clinical settings.
Nesrine Hassoun +5 more
doaj +1 more source
Antifungal resistance, combinations and pipeline: oh my!
Invasive fungal infections are a strong contributor to healthcare costs, morbidity and mortality, especially amongst hospitalized patients. Historically, Candida was responsible for approximately 15% of all nosocomial bloodstream infections.
Kayla R Stover +4 more
doaj +1 more source
Overcoming antifungal resistance [PDF]
Fungal infections have become one of the major causes of morbidity and mortality in immunocompromised patients. Despite increased awareness and improved treatment strategies, the frequent development of resistance to the antifungal drugs used in clinical settings contributes to the increasing toll of mycoses.
Anand, Srinivasan +2 more
openaire +2 more sources

